Related Insights
Petrochemical Trade Route Reshaping: How New Polymer Supply Chains Are Changing Global Procurement
Trade disruptions across the Middle East have accelerated a major shift in global polymer sourcing. This analysis explains how new trade routes are influencing procurement strategies, regional suppliers and long-term purchasing decisions for chemical buyers.

Iran Country Watch: The Internal Contradiction Between Diplomacy, Security and Parliament
Iran enters H2 2026 presenting three distinct institutional positions on diplomacy, maritime security and international engagement. For chemical buyers, understanding these competing policy signals is becoming as important as monitoring production capacity or sanctions compliance.

Ethanol and Industrial Solvents Market Review: H2 2026 Procurement Outlook
Ethanol and industrial solvent markets enter H2 2026 with changing supply dynamics across Brazil, India and China. Buyers should focus on contract timing, origin selection and duty-related cost changes.

MEG After India's Duty Reinstatement: Understanding the New Landed Cost Arithmetic for Polyester Buyers
India's reinstatement of the 5% Basic Customs Duty on MEG imports changes the cost equation for polyester manufacturers and chemical buyers. This article explains the new landed cost arithmetic, why today's costs remain below April's market peak and what procurement teams should monitor in the months ahead.

Ammonia Supply Recovery 2026: Why Indian Buyers Are Losing Negotiation Leverage
Ammonia availability in Q3 2026 is rebounding, shifting power back to sellers. Indian buyers, once dominant in phosphoric acid pricing, now face tighter margins and less bargaining room. Learn how supply dynamics reshape fertilizer procurement strategies.

Pharmaceutical Chemical Procurement Intelligence: June 24, 2026 Situation Report
Pharmaceutical procurement teams face an unusually complex H2 2026 environment shaped by GLP-1 manufacturing demand, excipient compliance changes, freight cost shifts, regulatory deadlines, and elevated drug shortage risk across critical therapeutic categories.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.

